ABSTRACT
In patients with pancreas divisum and recurrent acute pancreatitis, surgical and endoscopic minor sphincter otomy are equally effective.
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APRIL 2009 225 E ndoscopic therapy has become an alter native to surgery for some patients with acute recurrent pancreatitis, ie, those whose disease is caused by gallstones or other me chanical processes that can obstruct the out flow from the pancreas.
In this paper, we review the specific situations in which endoscopic therapy might be useful in patients with acute recurrent pancreatitis.
acute pancreatitis is managed ■ differently if it recurs
Recurrent acute pancreatitis is defined as more than one episode of acute pancreatitis. 1 In clinical practice, it is important to distinguish between the first and recurrent episodes of acute pancreatitis.
Most patients who have one episode of acute pancreatitis never have another one. 2, 3 Therefore, for patients having an initial at tack, we recommend a limited workup that includes a detailed history, laboratory evalua tion, and a noninvasive imaging study such as transcutaneous ultrasonography or computed tomography.
On the other hand, people who have a second attack are at higher risk of more recur rences. Therefore, patients having recurrent attacks need a more extensive workup to de termine the underlying cause. We recommend referring them to a gastroenterologist for fur ther evaluation.
ReCURRenT ACUTe PAnCReATiTiS hol abuse or gallstone disease. 2, 4 The rest are related to:
Autoimmune 
endoscopy is not completely benign
Although endoscopic procedures are less in vasive than surgery, they are not completely benign. They can cause anxiety and are as sociated with risks such as bleeding, perfora tion, and pancreatitis. 5 The risks, benefits, and alternatives to these procedures should be discussed with the patient, and informed con sent should be obtained before any endoscopic procedure. Gallstones can be large, but small stones (mi crolithiasis) and sludge are more common and therefore account for more cases of pancrea titis. Strictly defined, microlithiasis refers to stones smaller than 2 mm in diameter in the biliary tract, whereas sludge is a suspension of biliary crystals, mucin, and cellular debris in the gall bladder or bile ducts. 7 The terms are often used interchangeably, since the conditions often co exist and their treatment is similar.
Theories differ as to how microlithiasis or sludge can cause recurrent pancreatitis. Ac cording to one theory, the debris blocks the common channel, increasing the pancreatic intraductal pressure and leading to pancreati tis. 8 A second theory is that small stones or biliary crystals passing through the sphincter of Oddi cause inflammation, and that repeat ed inflammation eventually leads to stenosis or dyskinesia of the sphincter, both of which have been associated with pancreatitis. 9 Studies suggest that microlithiasis and sludge are common causes of recurrent pan creatitis, accounting for about twothirds of cases according to estimates by Ros et al 10 and Lee et al.
11
detecting small stones and sludge The diagnosis of microlithiasis and biliary sludge in patients with a gallbladder is based on imaging studies and bile microscopy.
12
Transabdominal ultrasonography is the imaging study most often used for diagnosing microlithiasis. The technology and expertise for this test are widely available, and it is rela tively inexpensive.
Endoscopic ultrasonography is more sen sitive for detecting microlithiasis and can ex amine the distal common bile duct.
Bile microscopy involves obtaining bile from the second portion of the duodenum (via an endoscope or a duodenal tube) or from the bile ducts (by cannulating the common bile duct and stimulating the gallbladder with cholecystokinin). The bile sample is centri fuged and inspected microscopically under plain light and polarized light (which aids the visualization of biliary crystals). The crystals can be cholesterol monohydrate, calcium bili rubinate, or calcium carbonate. 7, 13, 14 removing the gallbladder is the treatment of choice for small stones and sludge Treatments to prevent recurrent attacks of acute pancreatitis due to microlithiasis and sludge include cholecystectomy, biliary sphinc terotomy, and ursodioxycholic acid. 10, 11, 15 In prospective observational studies by Ros et al 10 and Lee et al, 11 about half of the pa tients with recurrent pancreatitis were treated with cholecystectomy, endoscopic sphinctero tomy, or ursodioxycholic acid in a nonran domized fashion. The choice of therapy was based on the patient's medical status and the The flow of bile and pancreatic juice can be obstructed because of stenosis or dyskinesia of any of the three sphincters known collectively as the sphincter of Oddi. The gold standard for diagnosis of sphincter of Oddi dysfunction is direct manometry via a thin catheter placed inside the pancreatic or biliary sphincter during ERCP.
Manometry catheter
Sphincter of Oddi
pancreas divisum
In patients with pancreas divisum who are prone to recurrent acute pancreatitis, endoscopic widening of the minor papilla (minor papillary sphincterotomy) is an effective treatment.
Minor papillary sphincterotomy
preferences of the patient and the physician. Half the patients received no treatment. In both studies the median followup was 4 years. Treated patients had a significantly lower rate of recurrent attacks of pancreatitis during fol lowup: less than 20% with therapy compared with more than 60% without therapy. Unfor tunately, no published study has compared these three treatments head to head. Cholecystectomy, however, is the most definitive therapy and is generally considered the treatment of choice.
Biliary sphincterotomy is an endoscopic procedure that involves cutting the sphincter of Oddi to allow the stones and sludge to pass more freely. It is as effective as cholecystec tomy in preventing recurrent attacks but does not eliminate the risk of cholecystitis and cholangitis (figure 1). For this reason, it is usu ally reserved for patients who cannot tolerate surgery due to comorbidities, those who refuse surgery, or those who are pregnant.
16
Ursodeoxycholic acid is a reasonable alter native in patients who cannot tolerate surgi cal or endoscopic biliary sphincterotomy. 1, [17] [18] [19] [20] The dosage is 10 mg/kg/day, which can be in two or three divided doses. The optimal dura tion of treatment is not known; however, since this drug works slowly, it may need to be taken for 2 years or more. Ursodeoxycholic acid is more effective in patients with cholesterol based stones and crystals. It is not effective for large stones (> 1 cm in diameter) or calcified stones.
stones after cholecystectomy ■
Bile duct stones can be classified as primary or secondary. A primary stone is one that re mains where it was formed, whereas a second ary stone is one that has migrated from its site of formation. 21 Some suggest that bile duct stones that are detected within 2 years of cholecystectomy originated in the gallbladder and were missed when the gallbladder was removed (and there fore are considered secondary stones), and that stones that present more than 2 years af ter cholecystectomy are de novo (ie, primary) stones. 22, 23 In any event, stones have been found in the common bile duct in 4% to 24% of pa tients up to 15 years after cholecystectomy. [24] [25] [26] A fair number of these patients have no symp toms. 27 Risk factors for stone recurrence are lithogenic bile (ie, high concentration of cholesterol, low concentration of bile salts), biliary stasis, strictures, dilated bile ducts, and advanced age. [28] [29] [30] no role for crystal analysis after cholecystectomy Biliary crystal analysis does not seem to have diagnostic value in patients with recurrent acute pancreatitis after cholecystectomy, 31 be cause removing the gallbladder eliminates the crystals and sludge. Imaging studies are there fore the cornerstone of diagnosis.
Transabdominal ultrasonography is the most commonly used initial imaging test. However, abdominal fat and gas in the duode num can obscure the distal common bile duct and decrease the sensitivity of this test.
32
Endoscopic ultrasonography involves po sitioning the transducer in the second part of the duodenum, where it can show the adja cent biliary tree without interference from di gestive gas or abdominal fat.
Magnetic resonance cholangio pancreatography (MRCP) and endoscopic ultrasonog raphy are both highly sensitive for detecting common bile duct stones and are recommend ed if they can be done without delay.
Endoscopic retrograde cholangiopancreatography (ERCP). As a rule, patients who are very likely to have gallstones are best served by proceeding directly to ERCP, a procedure that enables both imaging and treatment. However, ERCP exposes the patient to radia tion and the risk of pancreatitis, so in some patients (eg, pregnant women, people who re cently had acute pancreatitis), one may want to do ultrasonography first.
ercp is the treatment of choice after cholecystectomy The treatment of choice in patients with cho ledocholithiasis is ERCP with biliary sphinc terotomy and stone extraction. Success at clearing the biliary tree of all stones depends on the size, number, and location of the stones, the anatomy of the digestive tract and the bile duct, and the experience of the endoscopist. At specialized centers, the rate of successful clear The sphincter of Oddi, located where the bile and pancreatic ducts penetrate the wall of the duodenum, actually consists of three sphinc ters: the common, the biliary, and the pancre atic. Its physiologic role is to regulate the flow of bile and pancreatic juice into the duode num and to prevent reflux into the ducts from the duodenum. 34 Its basal pressure is the main regulating mechanism for pancreatic and bil iary secretions into the intestine, and its pha sic contractile activity is closely associated with duodenal motility.
sphincter dysfunction: stenosis, dyskinesia
The sphincter of Oddi can obstruct the flow of bile and pancreatic juice owing either to stenosis or to dyskinesia. 35, 36 Stenosis refers to structural alteration of the sphincter, probably from inflammation and subsequent fibrosis. In contrast, dyskinesia refers to a motor abnor mality of the sphincter that makes it hyper tonic.
Stenosis or dyskinesia can occur in the bil iary sphincter, the pancreatic sphincter, the common sphincter, or any combination of the three. For example, dysfunction of the biliary sphincter can cause abnormalities in liveras sociated enzyme levels and biliarytype pain, whereas pancreatic sphincter dysfunction can cause recurrent attacks of pancreatitis and pancreatictype pain. 37 Elevated pancreatic sphincter pressure has been shown to corre late with increased pancreatic ductal pressure, suggesting that the sphincter plays a role in the pathogenesis of acute pancreatitis. 23, 38 sphincter pressure can be measured during ercp, but ercp is risky The gold standard for the diagnosis of sphinc ter of Oddi dysfunction is manometry, 23, 35 ie, direct measurement of sphincter pressure via a thin catheter placed inside the pancreatic or biliary sphincter during ERCP ( figure 1) .
However, in patients with suspected sphincter of Oddi dysfunction, ERCP with or without manometry is associated with a high rate of complications, with pancreatitis occur ring in up to 25% of cases. [39] [40] [41] Therefore, sev eral noninvasive and provocative tests have been designed in an attempt to identify pa tients with this disorder. Unfortunately, none of them seems to be as sensitive and specific as manometry for diagnosing sphincter of Oddi dysfunction, and so they have not gained widespread use.
opening the sphincter of oddi with drugs, endoscopy, or surgery
Drug treatment of sphincter of Oddi dys function is based on drugs that relax smooth muscle, such as calcium channel blockers and nitrates. The treatment must be lifelong. Also, it does not improve sphincter stenosis, and only half of patients with sphincter dys kinesia respond to it. For these reasons, drug treatment of sphincter of Oddi dysfunction has not gained widespread acceptance.
36,42
Endoscopic sphincterotomy is the current standard endoscopic therapy for sphincter of Oddi dysfunction. This procedure is performed during ERCP and involves cutting the sphinc ter with electrocautery.
Endoscopic pancreatic sphincterotomy prevents recurrent attacks of pancreatitis in patients with pancreatic sphincter dysfunction in more than 60% of cases. 23, [43] [44] [45] [46] A potential complication is pancreatitis, which occurs more often in patients with pancreatic sphinc ter dyskinesia. Placing a stent in the pancre atic duct after pancreatic sphincterotomy re duces the risk of pancreatitis after ERCP. 37, 47, 48 Surgery. Pancreatic sphincterotomy can also be done surgically, most commonly via transduodenal pancreatic sphincteroplasty. Surgical sphincteroplasty is as effective as en doscopic sphincterotomy for preventing re current attacks of pancreatitis in patients with pancreatic sphincter dysfunction. 49 However, endoscopic therapy is much less invasive and remains the preferred treatment for sphincter of Oddi dysfunction in most centers with ex perience in this technique. 50 
pancreas diVisum ■
Pancreas divisum is the most common con genital anomaly of the pancreatic duct. Au topsy studies show it occurs in 5% to 10% of Stones have been found in 4%-24% of patients up to 15 years after cholecystectomy eRCP poses a risk of pancreatitis, especially in those with sphincter of oddi dysfunction the population. [51] [52] [53] At approximately the 5th week of gesta tion, there are two pancreatic buds: a ventral and a dorsal bud. The ventral bud eventually gives rise to part of the pancreatic head and uncinate process of the pancreas in the adult. The dorsal bud eventually gives rise to the rest of the pancreatic head, the pancreatic body, and the pancreatic tail. At 6 to 7 weeks of ges tation, the ventral bud rotates clockwise and lies posterior to the dorsal bud. At this stage, both the dorsal and ventral pancreata have their own ducts, which do not communicate with each other. Normally, the ventral and dorsal pancreas and their ducts fuse together at 8 weeks of gestation; in people with pan creas divisum, this ductal fusion does not oc cur. 51 The pancreas secretes 1.5 L of fluid per day. Normally, 90% to 95% of this volume drains through the major papilla. In people with pan creas divisum, 90% to 95% of the fluid drains through the minor papilla.
People with pancreas divisum are a hetero geneous group. Most have no symptoms, and their ductal anatomy is diagnosed only inci dentally. However, a subgroup is prone to de velop acute pancreatitis. The cause is thought to be the small diameter of the minor papilla, which poses a relative obstruction to the flow of pancreatic juice. 54 Direct support for this theory comes from a study in which investi gators measured pancreatic ductal pressures in eight people with normal anatomy and six people with pancreas divisum. The pressure in the main pancreatic duct in those with pan creas divisum was significantly higher than in those with normal anatomy. 55 Additional evi dence in favor of this theory is the effective ness of treatment, which involves widening the minor papillary opening (minor papillary sphincterotomy).
diagnosis of pancreas divisum
The diagnosis of pancreas divisum is based on imaging studies, and ERCP remains the gold standard for patients with equivocal results on noninvasive imaging. However, MRCP, espe cially secretinenhanced MRCP, is as accurate as ERCP. In most cases, MRCP has replaced ERCP for the diagnosis of this condition, al though a recent study suggests that MRCP is inferior to ERCP in the diagnosis of pancreas divisum. 56 We recommend secretinenhanced MRCP for this purpose.
Computed tomography and endoscopic ultrasonography can also diagnose pancreas divisum, but their diagnostic accuracy is lower than that of ERCP and MRCP. minor papillary sphincterotomy Treating recurrent pancreatitis due to pan creas divisum involves relieving the relative obstruction of the minor papilla by minor pap illary sphincterotomy. This can be done surgi cally or endoscopically ( figure 1) .
Surgery. No randomized, controlled study has yet assessed the efficacy of surgical sphinc teroplasty for recurrent pancreatitis in patients with pancreas divisum. However, retrospec tive studies and one prospective study have been published. 57, 58 In the retrospective study with the largest number of patients, Warshaw et al 57 reported their experience in 49 patients who had recur rent pancreatitis due to pancreas divisum. Af ter surgical sphincteroplasty, the patients were followed for a mean of 53 months; 40 (82%) of the 49 patients had no further episodes of acute pancreatitis during this time.
Bradley and Stephan 58 studied 37 patients with pancreas divisum and recurrent pancrea titis. 58 After surgical sphincteroplasty, the pa tients were followed for a mean of 60 months; 31 of the 37 patients had no further attacks, a success rate of 84%.
Endoscopic therapy. As with surgical ther apy trials, most trials of endoscopic therapy of recurrent pancreatitis in patients with pancre as divisum are small case series. In a retrospec tive study with one of the largest number of patients, Heyries et al 59 reported their experi ence with 24 patients with pancreas divisum and recurrent pancreatitis. After undergoing endoscopic minor papillary sphincterotomy, all patients were followed for a mean of 39 months, during which 22 (92%) did not have further episodes of acute pancreatitis.
In the only randomized controlled trial available, 19 patients with recurrent pancrea titis and pancreas divisum underwent either no treatment or endoscopic minor papillary sphincterotomy. 60 In the treatment group, 9 of 10 patients had no further episodes of acute pancreatitis during the 3 years of followup, while 6 of 9 patients who were randomized to no treatment had at least one episode. 60 Although surgical and endoscopic minor papillary sphincterotomy are equally effec tive, endoscopic therapy is preferred since it is less invasive, is associated with less morbid ity, and costs less. It is also more convenient for patients, since it is an outpatient proce dure. Surgical treatment is usually reserved for those in whom endoscopic treatment has failed or is not technically possible.
other processes obstructing ■ the floW of pancreatic Juice
Any process preventing free flow of pancreatic juice can lead to acute pancreatitis. The cause of the blockage can be around the ampulla, in the ampulla, or in the duct. 61 Periampullary lesions, tumors, or polyps can press on the ampulla and cause complete or relative obstruction of the pancreatic duct with a subsequent increase in intraductal pres sure and, thus, acute pancreatitis. 62 Tumors or polyps of the ampulla, such as ampullary ade noma or carcinoma, can cause pancreatitis by directly obstructing the pancreatic duct where it opens into the duodenum. [63] [64] [65] [66] Intraductal processes such as ductal adenocarcinoma, in traductal papillary mucinous tumor, pancre atic duct stone, and intraductal stricture due to cancer, chronic pancreatitis, or trauma can also cause pancreatitis by preventing free flow of pancreatic juice. [67] [68] [69] [70] [71] Although it is well known that sequelae of severe chronic pancreatitis such as duc tal strictures or intraductal stones can lead to recurrent attacks of acute pancreatitis by preventing the free flow of pancreatic juice, a relationship also seems to exist between early chronic pancreatitis and recurrent acute pan creatitis. 72 Several studies have shown that up to 50% of patients with idiopathic recur rent pancreatitis have evidence of chronic pancreatitis. [72] [73] [74] However, it is still unclear whether early chronic pancreatitis is the underlying cause of the recurrent attacks of acute pancreatitis or whether recurrent at tacks of acute pancreatitis might have led to the development of chronic pancreatitis. 
treatment
The treatment is to relieve the obstruction and reestablish the free flow of pancreatic juice. Periampullary tumors or polyps can be re sected surgically or, if they involve only the mucosa, by endoscopic mucosal resection. Ampullary adenomas can be resected endo scopically. Ampullary carcinomas usually re quire surgical resection.
Small, nonobstructive stones in the pan creatic duct can be removed during ERCP. 75 Larger stones may need to be fragmented by extracorporeal shock wave lithotripsy to fa cilitate removal by ERCP. 75 Intraductal strictures should raise the suspi cion of pancreatic adenocarcinoma, especially in older patients. 61 In these cases, relief of the obstruction by placement of a pancreatic stent can prevent further attacks of pancreatitis un til a diagnosis can be established and a more definitive treatment can be offered.
■
Any process preventing free flow of pancreatic juice can lead to acute pancreatitis reference ■
